BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

Clinical trial NCT07679919 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07679919
Sponsor: Luminary Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Hairy Cell Leukemia Multiple Myeloma

Start date: 2026-09-01
Primary completion: 2029-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.